Pharmacology and Toxicology
Showing page 16 of 22 pages of list content
-
Molecular determinants of vascular transport of dexamethasone in COVID-19 therapy
This article's authors -
Human embryonic stem cell-derived cardiomyocytes express SARS-CoV-2 host entry proteins: screen to identify inhibitors of infection
This article's authors -
Sofosbuvir Terminated RNA is More Resistant to SARS-CoV-2 Proofreader than RNA Terminated by Remdesivir
This article's authors -
Boceprevir, calpain inhibitors II and XII, and GC-376 have broad-spectrum antiviral activity against coronaviruses in cell culture
This article's authors -
Identification of 14 Known Drugs as Inhibitors of the Main Protease of SARS-CoV-2
This article's authors -
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening
This article's authors -
Methylene Blue Inhibits In Vitro the SARS-CoV-2 Spike – ACE2 Protein-Protein Interaction – A Mechanism That Can Contribute to Its Antiviral Activity Against COVID-19
This article's authors -
First-described recently discovered non-toxic vegetal-derived furocoumarin preclinical efficacy against SARS-CoV-2: a promising antiviral herbal drug
This article's authors -
Rejuveinix Mitigates Sepsis-Associated Oxidative Stress in the Brain of Mice: Clinical Impact Potential in COVID-19 and Nervous System Disorders
This article's authors -
A phenomics approach forin vitroantiviral drug discovery
This article's authors